Back to Global NewsPublished: 23 Feb 2026Download AppJoin TelegramWhy Merck’s 2028 Keytruda Patent Cliff Triggers a Radical Split – What Investors Must Watch#Merck#Keytruda#pharma#investment#healthcare#stock analysisDownload AppJoin CommunityShare Article